Skip to main content
Livermore
Livermore
ZHEN

Antares Pharma, Inc.

ATRSDelisted May 24, 2022
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001016169

Antares Pharma, Inc. was delisted on May 24, 2022; its insiders filed their last Form 4 on May 26, 2022; 177 institutions reported holding it in 13F filings for Q1 2022, worth $374.8M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Antares Pharma, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of ATRS: Q1 2021 compared with Q2 2021
MeasureQ1 2021Of which not filed for Q2 2021Q2 2021Change
Holders1711175+5
Shares82.5M1.13M82.1M+754.7K (+0.9%)
Value$339.5M$4.64M$358.2M+$23.3M (+7.0%)

1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held Antares Pharma, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to ATRS in Q2 2021
InstitutionSharesValue% of portfolio
First Wilshire Securities Management Inc2,535,727$11.1M3.87%
Amundi2,125,761$9.27M0.01%
Janus Henderson Group PLC175,968$767.0K0.00%
Squarepoint Ops LLC127,060$554.0K0.00%
Summit Global Investments116,500$508.0K0.03%
Clearline Capital LP81,764$356.0K0.05%
HRT Financial LP79,484$346.0K0.00%
TownSquare Capital, LLC64,165$295.0K0.01%
State of Wisconsin Investment Board62,777$274.0K0.00%
Spouting Rock Asset Management, LLC51,213$223.0K0.07%
Exane Derivatives34,246$150.3K0.04%
First Quadrant L P28,200$123.0K0.01%
Vontobel Holding Ltd.26,086$114.0K0.00%
Carderock Capital Management Inc25,000$109.0K0.03%
Ergoteles LLC24,600$107.0K0.00%
Jump Financial, LLC22,900$100.0K0.01%
Clear Harbor Asset Management, LLC21,000$92.0K0.01%
XTX Topco Ltd20,657$90.0K0.03%
Man Group plc17,900$78.0K0.00%
Profund Advisors LLC16,300$72.0K0.00%
Wedbush Securities Inc16,485$72.0K0.00%
Capital Advantage, Inc.13,000$57.0K0.01%
Envestnet Asset Management Inc12,367$54.0K0.00%
Advisory Services Network, LLC9,500$41.0K0.00%
Sargent Bickham Lagudis LLC450$2.00K0.00%
Glassman Wealth Services42$00.00%

Sold out (21)

Institutions that held Antares Pharma, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of ATRS in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Centric Wealth Management3,337,449$13.7M
State of New Jersey Common Pension Fund D512,392$2.11M
California Public Employees Retirement System334,300$1.37M
Mackay Shields LLC256,100$1.05M
Qube Research & Technologies Ltd88,984$366.0K
SEI Investments Co33,619$131.0K
Altshuler Shaham Ltd24,404$100.0K
Jane Street Group, LLC21,799$90.0K
Bridgefront Capital, LLC21,061$87.0K
Bridgeway Capital Management, LLC20,100$83.0K
Virtu Financial LLC19,920$82.0K
Wolverine Trading, LLC17,895$72.0K
HighVista Strategies LLC17,156$70.0K
Lazard Asset Management LLC15,178$62.0K
Kelman-Lazarov, Inc.15,000$62.0K
Creative Planning13,500$55.0K
Costello Asset Management, INC10,000$41.0K
Northwestern Mutual Wealth Management Co7,567$31.0K
Point72 Hong Kong Ltd1,697$7.00K
Eaton Vance Management1,253$5.00K
Sowell Financial Services LLC1,231$4.00K

Not filed for Q2 2021 yet (1)

Institutions that held Antares Pharma, Inc. at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ATRS in Q1 2021 that haven't filed for Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Amundi Asset Management US, Inc.1,129,569$4.64M